Cargando…
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
Autores principales: | Hardy, Michaël, Michaux, Isabelle, Lessire, Sarah, Douxfils, Jonathan, Dogné, Jean-Michel, Bareille, Marion, Horlait, Geoffrey, Bulpa, Pierre, Chapelle, Céline, Laporte, Silvy, Testa, Sophie, Jacqmin, Hugues, Lecompte, Thomas, Dive, Alain, Mullier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585359/ https://www.ncbi.nlm.nih.gov/pubmed/33161283 http://dx.doi.org/10.1016/j.thromres.2020.10.025 |
Ejemplares similares
-
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data
por: Hardy, Michaël, et al.
Publicado: (2020) -
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
por: Lardinois, Benjamin, et al.
Publicado: (2022) -
Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study
por: Hardy, M., et al.
Publicado: (2023) -
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’
por: Hardy, M., et al.
Publicado: (2022) -
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
por: Hardy, M., et al.
Publicado: (2020)